Lipid-Lowering Agents and the Risk of Cognitive Impairment That Does Not Meet Criteria for Dementia, in Relation to Apolipoprotein E Status

Publisher： Karger

E-ISSN： 1423-0208|29|3-4|201-207

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.29, Iss.3-4, 2007-11, pp. : 201-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 2, 2000-02 ,pp. : 70-73

Karger

Access to resources Recommend Favorite

Apolipoprotein E Genotype, Vascular Risk and Early Cognitive Impairment in an African Caribbean Population

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 251-256

Karger

Access to resources Recommend Favorite

Apolipoprotein E Polymorphism and Brain Morphology in Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 4, 2008-10 ,pp. : 300-305

Karger

Access to resources Recommend Favorite

Does Vascular Burden Contribute to the Progression of Mild Cognitive Impairment to Dementia?

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 3-4, 2012-11 ,pp. : 235-243

Karger

Access to resources Recommend Favorite

Sensitivity of the Dementia Rating Scale in Vascular Dementia: Comparison between Two Sets of Criteria to Define Cognitive Impairment

By  

Cerebrovascular Diseases, Vol. 15, Iss. 1-2, 2003-01 ,pp. : 116-120

Karger

Access to resources Recommend Favorite